Physician profile
Darrell S Reisner
NPI 1912095019
$4,986.13
in general payments reported to CMS, 2019-2025
24 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $250 · 2021: $702 · 2022: $847 · 2023: $1,168 · 2024: $858 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,536 · Long Term Medical Supply Or Device Loan: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,536.44 |
| Long Term Medical Supply Or Device Loan | $195.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,069.45 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $673.04 | 2019-2025 | Cequa |
| Alcon Vision LLC | $600.97 | 2019-2025 | Clareon Panoptix Pro, Eysuvis, Clareon |
| Kala Pharmaceuticals, INC. | $337.55 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $280.55 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $226.21 | 2019-2021 | |
| Allergan, INC. | $200.06 | 2020-2022 | |
| Carl Zeiss Meditec USA, INC. | $195.37 | 2023 | Cirrus 5000 With Angioplex |
| Novartis Pharmaceuticals Corporation | $181.63 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $176.24 | 2019-2023 | Tecnis Iol |
| Oyster Point Pharma, INC. | $154.28 | 2022-2023 | Tyrvaya |
| Notal Vision, INC. | $135.88 | 2022 | |
| Bausch & Lomb Americas INC. | $126.28 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| New World Medical,INC. | $126.13 | 2022 | |
| Dompe US, INC. | $117.75 | 2023-2025 | Oxervate |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $78.17 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Glaukos Corporation | $58.46 | 2025 | Idosetr |
| Aerie Pharmaceuticals, INC. | $53.04 | 2019 | |
| Thea Pharma INC. | $47.40 | 2024-2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $45.69 | 2019-2021 | |
| Harrow Eye, LLC | $35.42 | 2024 | Vevye |
| Ivantis, INC | $34.39 | 2021 | |
| Alimera Sciences, INC. | $16.25 | 2022 | |
| Lensar, INC. | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Reisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.